Beijing Konruns PharmaceuticalLtd Gelecekteki Büyüme
Future kriter kontrolleri 5/6
Beijing Konruns PharmaceuticalLtd is forecast to grow earnings and revenue by 34.3% and 24.1% per annum respectively. EPS is expected to grow by 33.9% per annum. Return on equity is forecast to be 7.9% in 3 years.
Anahtar bilgiler
34.3%
Kazanç büyüme oranı
33.9%
EPS büyüme oranı
Pharmaceuticals kazanç büyümesi | 19.3% |
Gelir büyüme oranı | 24.1% |
Gelecekteki özkaynak getirisi | 7.9% |
Analist kapsamı | Low |
Son güncelleme | 14 Jun 2024 |
Gelecekteki son büyüme güncellemeleri
Güncelleme yok
Kazanç ve Gelir Büyüme Tahminleri
Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
---|---|---|---|---|---|
12/31/2026 | 1,556 | 295 | N/A | 402 | 2 |
12/31/2025 | 1,283 | 235 | N/A | 339 | 2 |
12/31/2024 | 1,077 | 186 | N/A | 320 | 2 |
9/30/2024 | 846 | 115 | 49 | 165 | N/A |
6/30/2024 | 874 | 137 | 132 | 238 | N/A |
3/31/2024 | 954 | 166 | 126 | 229 | N/A |
12/31/2023 | 920 | 150 | 98 | 199 | N/A |
9/30/2023 | 999 | 146 | 67 | 134 | N/A |
6/30/2023 | 946 | 112 | 51 | 97 | N/A |
3/31/2023 | 876 | 81 | -10 | 77 | N/A |
12/31/2022 | 867 | 101 | 23 | 120 | N/A |
9/30/2022 | 801 | 114 | 61 | 201 | N/A |
6/30/2022 | 726 | 130 | -38 | 152 | N/A |
3/31/2022 | 755 | 130 | -96 | 82 | N/A |
12/31/2021 | 810 | 148 | -108 | 56 | N/A |
9/30/2021 | 855 | 179 | -141 | -20 | N/A |
6/30/2021 | 916 | 180 | -141 | -54 | N/A |
3/31/2021 | 949 | 216 | -24 | 28 | N/A |
12/31/2020 | 809 | 183 | 8 | 58 | N/A |
9/30/2020 | 855 | 204 | 83 | 119 | N/A |
6/30/2020 | 870 | 220 | 186 | 208 | N/A |
3/31/2020 | 944 | 249 | 238 | 255 | N/A |
12/31/2019 | 1,066 | 266 | 243 | 262 | N/A |
9/30/2019 | 1,038 | 311 | 266 | 285 | N/A |
6/30/2019 | 1,029 | 313 | 303 | 317 | N/A |
3/31/2019 | 982 | 273 | 308 | 327 | N/A |
12/31/2018 | 973 | 264 | 246 | 263 | N/A |
9/30/2018 | 897 | 215 | 250 | 273 | N/A |
12/31/2017 | 591 | 479 | N/A | 270 | N/A |
12/31/2016 | 346 | 192 | N/A | 148 | N/A |
12/31/2015 | 436 | 195 | N/A | 192 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: 603590's forecast earnings growth (34.3% per year) is above the savings rate (2.9%).
Kazançlar ve Piyasa: 603590's earnings (34.3% per year) are forecast to grow faster than the CN market (25.8% per year).
Yüksek Büyüme Kazançları: 603590's earnings are expected to grow significantly over the next 3 years.
Gelir ve Pazar: 603590's revenue (24.1% per year) is forecast to grow faster than the CN market (14% per year).
Yüksek Büyüme Geliri: 603590's revenue (24.1% per year) is forecast to grow faster than 20% per year.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: 603590's Return on Equity is forecast to be low in 3 years time (7.9%).